Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C70H126N3O26P |
Molecular Weight | 1456.7277 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 16 / 16 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]3(O[C@H]1[C@@H](O)[C@@H](CO)O[C@@]([H])(O[C@@H]2[C@@H](CO)O[C@@H](OCCCNC(=O)CCCCC(=O)NCCOP(O)(=O)OC[C@@H](COC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H](NC(C)=O)[C@H]2O)[C@@H]1O)O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O
InChI
InChIKey=ZJYQGJWRGLACDM-UNBAAJOISA-N
InChI=1S/C70H126N3O26P/c1-4-6-8-10-12-14-16-18-20-22-24-26-28-30-32-39-57(80)91-48-51(94-58(81)40-33-31-29-27-25-23-21-19-17-15-13-11-9-7-5-2)49-93-100(88,89)92-44-42-72-56(79)38-35-34-37-55(78)71-41-36-43-90-68-59(73-50(3)77)62(84)66(54(47-76)97-68)98-70-65(87)67(61(83)53(46-75)96-70)99-69-64(86)63(85)60(82)52(45-74)95-69/h18-21,51-54,59-70,74-76,82-87H,4-17,22-49H2,1-3H3,(H,71,78)(H,72,79)(H,73,77)(H,88,89)/b20-18-,21-19-/t51-,52-,53-,54-,59-,60+,61+,62-,63+,64-,65-,66-,67+,68-,69-,70+/m1/s1
Molecular Formula | C70H125N3O26P |
Molecular Weight | 1455.7198 |
Charge | -1 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 16 / 16 |
E/Z Centers | 2 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 15:40:08 GMT 2023
by
admin
on
Sat Dec 16 15:40:08 GMT 2023
|
Record UNII |
OE0L4ZX3I8
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C165548
Created by
admin on Sat Dec 16 15:40:08 GMT 2023 , Edited by admin on Sat Dec 16 15:40:08 GMT 2023
|
PRIMARY | |||
|
1821461-84-0
Created by
admin on Sat Dec 16 15:40:08 GMT 2023 , Edited by admin on Sat Dec 16 15:40:08 GMT 2023
|
PRIMARY | |||
|
300000033238
Created by
admin on Sat Dec 16 15:40:08 GMT 2023 , Edited by admin on Sat Dec 16 15:40:08 GMT 2023
|
PRIMARY | |||
|
92131145
Created by
admin on Sat Dec 16 15:40:08 GMT 2023 , Edited by admin on Sat Dec 16 15:40:08 GMT 2023
|
PRIMARY | |||
|
OE0L4ZX3I8
Created by
admin on Sat Dec 16 15:40:08 GMT 2023 , Edited by admin on Sat Dec 16 15:40:08 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->LIGAND |
After intratumor injections anti-bodies target tumor cells due to the insertion of the alpha-gal lipids in the cellular membrane.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|